Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biodentine vs Theracal LC for Indirect Pulp Capping in Primary Molars
NCT06020911Phase 4Completed
- Sponsor
- Tanta University
- Start
- Jan 2023
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of TheraCal LC in dental caries (2 arms), sponsored by Tanta University. Primary endpoints: Thickness of dentin at 9 months, Radiodensity at 9 months and 1 more. Started Jan 2023; status: completed.
02
Drugs
TheraCal LC
03
Conditions
dental caries
Beyond the preview
Go deeper on NCT06020911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06020911.